Daniel K. Spiegelman - May 27, 2021 Form 4 Insider Report for MYRIAD GENETICS INC (MYGN)

Role
Director
Signature
By: Nathan A. Smith For: Daniel K. Spiegelman
Stock symbol
MYGN
Transactions as of
May 27, 2021
Transactions value $
$0
Form type
4
Date filed
5/28/2021, 06:48 PM
Previous filing
May 21, 2021
Next filing
Jun 1, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MYGN Common Stock Disposed to Issuer $0 -15.9K -43.59% $0.00 20.6K May 27, 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On May 27, 2021, the Company rescinded Mr. Spiegelman's grant of 15,889 restricted stock units granted on December 4, 2020 and reported on the Form 4 filed with the Securities and Exchange Commission on December 7, 2020.